Terms: = Endocrine gland cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
791 results:
1. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
2. Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology.
Kango G; Malek R; Mannuel H; Hussain A
Curr Opin Oncol; 2024 May; 36(3):195-201. PubMed ID: 38573209
[TBL] [Abstract] [Full Text] [Related]
3. Lymph Node Dissection in Testicular cancer: The State of the Art and Future Perspectives.
Małkiewicz B; Świrkosz G; Lewandowski W; Demska K; Szczepaniak Z; Karwacki J; Krajewski W; Szydełko T
Curr Oncol Rep; 2024 Apr; 26(4):318-335. PubMed ID: 38430323
[TBL] [Abstract] [Full Text] [Related]
4. Current Status and Future Direction in the treatment of Advanced Adrenocortical Carcinoma.
Pak C; Yoon S; Lee JL; Yun T; Park I
Curr Oncol Rep; 2024 Apr; 26(4):307-317. PubMed ID: 38381366
[TBL] [Abstract] [Full Text] [Related]
5. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
6. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
7. Testicular cancer with small metastatic burden: optimal approach in 2024.
Yuen KL; Pandit K; Puri D; Yodkhunnatham N; Bagrodia A
Curr Opin Urol; 2024 May; 34(3):204-209. PubMed ID: 38305430
[TBL] [Abstract] [Full Text] [Related]
8. PARP Inhibitors in Breast cancer: a Short Communication.
Daly GR; AlRawashdeh MM; McGrath J; Dowling GP; Cox L; Naidoo S; Vareslija D; Hill ADK; Young L
Curr Oncol Rep; 2024 Feb; 26(2):103-113. PubMed ID: 38236558
[TBL] [Abstract] [Full Text] [Related]
9. Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer.
Chen L; Fan T; Wang M; Zhu CY; Feng WY; Li Y; Yang H
Expert Opin Ther Targets; 2024; 28(1-2):83-95. PubMed ID: 38235574
[TBL] [Abstract] [Full Text] [Related]
10. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era.
García-Illescas D; Mazzeo R; García-Durán C; Oaknin A
Curr Opin Obstet Gynecol; 2024 Apr; 36(2):104-111. PubMed ID: 38170620
[TBL] [Abstract] [Full Text] [Related]
11. A review of racial disparities in ovarian cancer and clinical trials.
Ali M; Tewari KS
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):23-27. PubMed ID: 38170549
[TBL] [Abstract] [Full Text] [Related]
12. Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
Salutari V; Giudice E; Lorusso D
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):9-17. PubMed ID: 38170548
[TBL] [Abstract] [Full Text] [Related]
13. cancer survivor late-effects, chronic health problems after cancer treatment: what's the evidence from population and registry data and where are the gaps?
Faithfull S; Greenfield D
Curr Opin Support Palliat Care; 2024 Mar; 18(1):55-64. PubMed ID: 38170192
[TBL] [Abstract] [Full Text] [Related]
14. Management of aggressive variants of papillary thyroid cancer.
Lee YK; Rovira A; Carroll PV; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):125-133. PubMed ID: 38116795
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.
Hu J; Jiang J; Xu B; Li Y; Wang B; He S; Ren X; Shi B; Zhang X; Zheng H; Hua B; Liu R
J Ethnopharmacol; 2024 Mar; 322():117590. PubMed ID: 38113986
[TBL] [Abstract] [Full Text] [Related]
16. Shifting Strategies in the treatment of Pediatric Craniopharyngioma.
Gabay S; Merchant TE; Boop FA; Roth J; Constantini S
Curr Oncol Rep; 2023 Dec; 25(12):1497-1513. PubMed ID: 38015373
[TBL] [Abstract] [Full Text] [Related]
17. Effectiveness and tolerance of electrochemotherapy as palliative therapy for patients with head and neck cancer and malignant melanoma and its relation to early skin reaction.
Caballero-Borrego M; Coll S; Navarrete P
Braz J Otorhinolaryngol; 2024; 90(1):101365. PubMed ID: 38006727
[TBL] [Abstract] [Full Text] [Related]
18. Hepatic Metastasectomy in Pediatric Patients: An Observational Study.
Fleming AM; Mansfield SA; Jancelewicz T; Gosain A; Eubanks JW; Davidoff AM; Langham MR; Murphy AJ
J Pediatr Surg; 2024 Feb; 59(2):247-253. PubMed ID: 37980196
[TBL] [Abstract] [Full Text] [Related]
19. Contemporary Trends in Laparoscopy and Ovarian Sparing Surgery for Ovarian Torsion in the Pediatric Population.
Huerta CT; Rodriguez C; Parreco J; Thorson CM; Sola JE; Perez EA
J Pediatr Surg; 2024 Mar; 59(3):393-399. PubMed ID: 37968152
[TBL] [Abstract] [Full Text] [Related]
20. The Broad Spectrum of Paediatric Pancreatic Disease: A Single-center 26-years Retrospective Review.
Alnagar A; Khamag O; Sharif K; Mirza DF; Ong EGP
J Pediatr Surg; 2024 Feb; 59(2):261-267. PubMed ID: 37957099
[TBL] [Abstract] [Full Text] [Related]
[Next]
